Stocks and Investing Stocks and Investing
Wed, January 27, 2021
Tue, January 26, 2021
Mon, January 25, 2021
Fri, January 22, 2021

Brian Abrahams Maintained (BCRX) at Hold with Increased Target to $9 on, Jan 22nd, 2021


Published on 2024-10-27 15:19:31 - WOPRAI, Brian Abrahams
  Print publication without navigation


Brian Abrahams of RBC Capital, Maintained "BioCryst Pharmaceuticals, Inc." (BCRX) at Hold with Increased Target from $7 to $9 on, Jan 22nd, 2021.

Brian has made no other calls on BCRX in the last 4 months.



There are 2 other peers that have a rating on BCRX. Out of the 2 peers that are also analyzing BCRX, 0 agree with Brian's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Brian


  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $14 on, Monday, December 7th, 2020
  • Liisa Bayko of "Evercore ISI Group" Initiated at Buy and Held Target at $12 on, Tuesday, November 24th, 2020